Ritonavir (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ritonavir" in Dutch language version.

refsWebsite

Global rank Dutch rank

12nih.gov

4^th place

12^th place

12doi.org

2^nd place

8^th place

7web.archive.org

1^st place

4fda.gov

447^th place

1,002^nd place

2drugs.com

399^th place

2,078^th place

2archive.org

6^th place

25^th place

2books.google.com

3^rd place

43^rd place

2archive.today

14^th place

26^th place

1europa.eu

68^th place

39^th place

1rxlist.com

7,927^th place

low place

1merck.com

6,464^th place

3,767^th place

1cdc.gov

218^th place

645^th place

1kaletra.com

low place

1washingtonpost.com

34^th place

111^th place

1clinicaltrialsarena.com

low place

1nationalpost.com

818^th place

1,436^th place

1racgp.org.au

low place

1pfizer.com

low place

8,960^th place

1usatoday.com

41^st place

193^rd place

1businesswire.com

615^th place

1,891^st place

archive.org

British National Formulary 69, 69. Pharmaceutical Pr (31 maart 2015), 426. ISBN 9780857111562.
(mei 2006). Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. Journal of Acquired Immune Deficiency Syndromes 42 (1): 52–60. PMID 16639344. DOI: 10.1097/01.qai.0000219774.20174.64.

archive.today

Kaletra FAQ. AbbVie's Kaletra product information. AbbVie (2011). Gearchiveerd op 7 juli 2014. Geraadpleegd op 5 juli 2014.
(en) "Pfizer is testing a pill that, if successful, could become first-ever home cure for COVID-19", The Telegraph, 26 april 2021. Gearchiveerd op 27 april 2021.

books.google.com

Pharmacology principles and practice. Academic Press/Elsevier, Amsterdam (2009), pp. 550. ISBN 9780080919225.
(en) Analogue-based Drug Discovery. John Wiley & Sons (2006), pp. 509. ISBN 9783527607495.

businesswire.com

Pfizer (5 november 2021). Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study. Persbericht. Geraadpleegd op 17 november 2021.

cdc.gov

Centers for Disease Control Prevention (CDC) (juni 2011). HIV surveillance--United States, 1981-2008. MMWR. Morbidity and Mortality Weekly Report 60 (21): 689–93. PMID 21637182. Gearchiveerd van origineel op 24 september 2015.

clinicaltrialsarena.com

Pfizer begins dosing in Phase II/III trial of antiviral drug for Covid-19.. Clinical Trials Arena (2 september 2021).

doi.org

(mei 2006). Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. Journal of Acquired Immune Deficiency Syndromes 42 (1): 52–60. PMID 16639344. DOI: 10.1097/01.qai.0000219774.20174.64.
(januari 2004). Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. The Journal of Antimicrobial Chemotherapy 53 (1): 4–9. PMID 14657084. DOI: 10.1093/jac/dkh029.
(juni 2001). Ritonavir: an extraordinary example of conformational polymorphism. Pharmaceutical Research 18 (6): 859–866. PMID 11474792. DOI: 10.1023/A:1011052932607.
(maart 2003). Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proceedings of the National Academy of Sciences of the United States of America 100 (5): 2180–2184. PMID 12604798. PMC 151315. DOI: 10.1073/pnas.0437744100.
(1 februari 2006). Crystal dissolution kinetics and Gibbs free energy. Journal of Electron Spectroscopy and Related Phenomena 150 (2): 248–259. DOI: 10.1016/j.elspec.2005.06.007.
(februari 2017). A Newly Discovered Racemic Compound of Pioglitazone Hydrochloride Is More Stable than the Commercial Conglomerate. Crystal Growth & Design 17 (2): 414–417. PMID 31537981. PMC 6752731. DOI: 10.1021/acs.cgd.6b01638.
(mei 2020). A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England Journal of Medicine 382 (19): 1787–1799. PMID 32187464. PMC 7121492. DOI: 10.1056/NEJMoa2001282.
(oktober 2020). Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding. Journal of Biomolecular Structure & Dynamics: 1–10. PMID 33030105. DOI: 10.1080/07391102.2020.1830854.
(augustus 2021). Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection. Current Opinion in Virology 49: 36–40. PMID 34029993. PMC 8075814. DOI: 10.1016/j.coviro.2021.04.006.
(september 2021). Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs. Antimicrobial Agents and Chemotherapy 65 (10): e0115521. PMID 34310217. PMC 8448143. DOI: 10.1128/AAC.01155-21.
(augustus 2021). Antiviral treatment of COVID-19: An update. Turkish Journal of Medical Sciences. PMID 34391321. DOI: 10.3906/sag-2106-250.
(augustus 2021). Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations. International Journal of Molecular Sciences 22 (17). PMID 34502033. PMC 8430524. DOI: 10.3390/ijms22179124.

drugs.com

Ritonavir. The American Society of Health-System Pharmacists. Gearchiveerd op 17 oktober 2015. Geraadpleegd op 23 oktober 2015.
Ritonavir Pregnancy and Breastfeeding Warnings. drugs.com. Gearchiveerd op 7 september 2015. Geraadpleegd op 23 oktober 2015.

europa.eu

ema.europa.eu

Norvir EPAR. European Medicines Agency (EMA). Geraadpleegd op 20 augustus 2020.

fda.gov

FDA approves Viekira Pak to treat hepatitis C. Food and Drug Administration (19 december 2014). Gearchiveerd op 31 oktober 2015.
First Generic Drug Approvals. U.S. Food and Drug Administration (FDA). Geraadpleegd op 13 februari 2021.
Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. U.S. Food and Drug Administration (FDA) (3 december 2019).

accessdata.fda.gov

Ritonavir FDA approval package (1 maart 1996).

kaletra.com

Kaletra FAQ. AbbVie's Kaletra product information. AbbVie (2011). Gearchiveerd op 7 juli 2014. Geraadpleegd op 5 juli 2014.

merck.com

"Ritonavir: Drug Information Provided by Lexi-Comp: Merck Manual Professional", Merck Manuals Professional Edition, 30 april 2008. Gearchiveerd op 30 april 2008.

nationalpost.com

(en) "Pfizer is testing a pill that, if successful, could become first-ever home cure for COVID-19", The Telegraph, 26 april 2021. Gearchiveerd op 27 april 2021.

nih.gov

ncbi.nlm.nih.gov

(mei 2006). Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. Journal of Acquired Immune Deficiency Syndromes 42 (1): 52–60. PMID 16639344. DOI: 10.1097/01.qai.0000219774.20174.64.
(januari 2004). Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. The Journal of Antimicrobial Chemotherapy 53 (1): 4–9. PMID 14657084. DOI: 10.1093/jac/dkh029.
Centers for Disease Control Prevention (CDC) (juni 2011). HIV surveillance--United States, 1981-2008. MMWR. Morbidity and Mortality Weekly Report 60 (21): 689–93. PMID 21637182. Gearchiveerd van origineel op 24 september 2015.
(juni 2001). Ritonavir: an extraordinary example of conformational polymorphism. Pharmaceutical Research 18 (6): 859–866. PMID 11474792. DOI: 10.1023/A:1011052932607.
(maart 2003). Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proceedings of the National Academy of Sciences of the United States of America 100 (5): 2180–2184. PMID 12604798. PMC 151315. DOI: 10.1073/pnas.0437744100.
(februari 2017). A Newly Discovered Racemic Compound of Pioglitazone Hydrochloride Is More Stable than the Commercial Conglomerate. Crystal Growth & Design 17 (2): 414–417. PMID 31537981. PMC 6752731. DOI: 10.1021/acs.cgd.6b01638.
(mei 2020). A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England Journal of Medicine 382 (19): 1787–1799. PMID 32187464. PMC 7121492. DOI: 10.1056/NEJMoa2001282.
(oktober 2020). Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding. Journal of Biomolecular Structure & Dynamics: 1–10. PMID 33030105. DOI: 10.1080/07391102.2020.1830854.
(augustus 2021). Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection. Current Opinion in Virology 49: 36–40. PMID 34029993. PMC 8075814. DOI: 10.1016/j.coviro.2021.04.006.
(september 2021). Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs. Antimicrobial Agents and Chemotherapy 65 (10): e0115521. PMID 34310217. PMC 8448143. DOI: 10.1128/AAC.01155-21.
(augustus 2021). Antiviral treatment of COVID-19: An update. Turkish Journal of Medical Sciences. PMID 34391321. DOI: 10.3906/sag-2106-250.
(augustus 2021). Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations. International Journal of Molecular Sciences 22 (17). PMID 34502033. PMC 8430524. DOI: 10.3390/ijms22179124.

pfizer.com

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study (5 november 2021).

racgp.org.au

www1.racgp.org.au

What is Australia's potential new COVID treatment?. The Royal Australian College of General Practitioners (RACGP) (19 oktober 2021). Geraadpleegd op 6 november 2021.

rxlist.com

Norvir side effects (Ritonavir) and drug interactions - prescription drugs and medications at RxList (27 juni 2007). Gearchiveerd op 27 juni 2007.

usatoday.com

Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests. USA Today (5 november 2021).

washingtonpost.com

Ceci Connolly, NIH Declines to Enter AIDS Drug Price Battle. The Washington Post (5 augustus 2004). Gearchiveerd op 20 augustus 2008. Geraadpleegd op 16 januari 2006.

web.archive.org

Ritonavir. The American Society of Health-System Pharmacists. Gearchiveerd op 17 oktober 2015. Geraadpleegd op 23 oktober 2015.
FDA approves Viekira Pak to treat hepatitis C. Food and Drug Administration (19 december 2014). Gearchiveerd op 31 oktober 2015.
Ritonavir Pregnancy and Breastfeeding Warnings. drugs.com. Gearchiveerd op 7 september 2015. Geraadpleegd op 23 oktober 2015.
Norvir side effects (Ritonavir) and drug interactions - prescription drugs and medications at RxList (27 juni 2007). Gearchiveerd op 27 juni 2007.
"Ritonavir: Drug Information Provided by Lexi-Comp: Merck Manual Professional", Merck Manuals Professional Edition, 30 april 2008. Gearchiveerd op 30 april 2008.
Centers for Disease Control Prevention (CDC) (juni 2011). HIV surveillance--United States, 1981-2008. MMWR. Morbidity and Mortality Weekly Report 60 (21): 689–93. PMID 21637182. Gearchiveerd van origineel op 24 september 2015.
Ceci Connolly, NIH Declines to Enter AIDS Drug Price Battle. The Washington Post (5 augustus 2004). Gearchiveerd op 20 augustus 2008. Geraadpleegd op 16 januari 2006.